Plasma lipidomics of monozygotic twins discordant for multiple sclerosis

Blood biomarkers of multiple sclerosis (MS) can provide a better understanding of pathophysiology and enable disease monitoring. Here, we performed quantitative shotgun lipidomics on the plasma of a unique cohort of 73 monozygotic twins discordant for MS. We analyzed 243 lipid species, evaluated lip...

Descripción completa

Detalles Bibliográficos
Autores principales: Penkert, Horst, Lauber, Chris, Gerl, Mathias J., Klose, Christian, Damm, Markus, Fitzner, Dirk, Flierl‐Hecht, Andrea, Kümpfel, Tania, Kerschensteiner, Martin, Hohlfeld, Reinhard, Gerdes, Lisa A., Simons, Mikael
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Brief Communications
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7732246/
https://www.ncbi.nlm.nih.gov/pubmed/33159711
http://dx.doi.org/10.1002/acn3.51216
Descripción
Sumario:Blood biomarkers of multiple sclerosis (MS) can provide a better understanding of pathophysiology and enable disease monitoring. Here, we performed quantitative shotgun lipidomics on the plasma of a unique cohort of 73 monozygotic twins discordant for MS. We analyzed 243 lipid species, evaluated lipid features such as fatty acyl chain length and number of acyl chain double bonds, and detected phospholipids that were significantly altered in the plasma of co‐twins with MS compared to their non‐affected siblings. Strikingly, changes were most prominent in ether phosphatidylethanolamines and ether phosphatidylcholines, suggesting a role for altered lipid signaling in the disease.

Ejemplares similares